Novel Liver Dialysis Device May Safely Curb ACLF medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
This article is a collaboration between MedPage Today and:
A novel liver dialysis device for patients with acute on chronic liver failure (ACLF) was safe compared to standard of care, a small randomized study found.
In a European multi-center trial of 32 patients, serious adverse events occurred in 11 patients treated with the Dialive extracorporeal liver assist device versus in eight patients receiving standard of care. Deaths in both groups were also comparable (four and three, respectively), reported Banwari Agarwal, MD, of Royal Free Hospital in London.
While efficacy was not the purpose of the study, data from this small group also found that the intervention was associated with improvements in organ function, and ACLF-free survival compared to standard of care.